ACTIVE

STUDIO PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

349,1 k €

-49.7% YoY

Gross margin

853 k €

-21.2% YoY

Equity

138,7 k €

-83.0% YoY

Workforce

4,9 ETP

-2.0% YoY

What does STUDIO PHARMA do?

STUDIO PHARMA is a Private limited company incorporated in 2006. Its main activity is: Management consultancy activities. Its registered office is in Aalter. It employs on average 4,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0883.309.219

Incorporation

05/09/2006

Legal form

Private limited company

Registered office

Artemeersstraat 11
9880 Aalter · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

4,9 ETP

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities 70210Public relations and communication activities 73300Advertising and market research 74141Specialised design activities

Joint committees (3)

200
2000
20000

Signals

ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	853 k €	-21.2%	1,1 M €	+17.9%	917,9 k €	+17.2%	783,3 k €	+44.3%	543 k €	+115%	252,4 k €	+51.3%	166,8 k €	+15.2%	144,8 k €	+14.2%	126,8 k €	+0.1%	126,6 k €	-6.5%	135,4 k €	-13.5%	156,5 k €	-2.6%	160,7 k €	+35.6%	118,5 k €	+147%	48 k €	+20.5%	39,8 k €	-19.6%	49,5 k €
EBITDA	464 k €	-34.5%	708,6 k €	+18.9%	595,7 k €	+24.0%	480,4 k €	+48.3%	323,8 k €	+55.0%	209 k €	+32.9%	157,3 k €	+9.6%	143,5 k €	+14.1%	125,7 k €	+0.4%	125,2 k €	-6.5%	133,9 k €	+1.2%	132,4 k €	-16.4%	158,4 k €	+71.6%	92,3 k €	+96.7%	46,9 k €	+20.5%	38,9 k €	-19.9%	48,6 k €
Operating result	452,4 k €	-34.1%	686,6 k €	+22.2%	562 k €	+25.4%	448 k €	+54.6%	289,7 k €	+62.2%	178,6 k €	+35.1%	132,2 k €	+2.8%	128,6 k €	+15.2%	111,6 k €	-0.7%	112,4 k €	-7.5%	121,5 k €	+0.7%	120,7 k €	-19.1%	149,2 k €	+63.4%	91,3 k €	+98.5%	46 k €	+34.0%	34,3 k €	-15.2%	40,5 k €
Net result	349,1 k €	-49.7%	694,6 k €	+83.5%	378,5 k €	+23.1%	307,5 k €	+48.9%	206,5 k €	+65.7%	124,7 k €	+54.0%	81 k €	+5.2%	77 k €	+19.6%	64,4 k €	-6.0%	68,5 k €	-14.7%	80,2 k €	+2.8%	78 k €	-21.1%	98,9 k €	+63.7%	60,4 k €	+77.8%	34 k €	+58.7%	21,4 k €	-28.3%	29,9 k €
Balance sheet
Equity	138,7 k €	-83.0%	815 k €	-37.3%	1,3 M €	+29.7%	1 M €	+21.0%	827,4 k €	+88.3%	439,5 k €	+38.1%	318,3 k €	+34.1%	237,3 k €	+48.0%	160,4 k €	-1.6%	163 k €	+72.4%	94,5 k €	+561%	14,3 k €	-87.4%	113,7 k €	+671%	14,7 k €	-83.9%	91,7 k €	+58.9%	57,7 k €	+59.1%	36,3 k €
Total assets	1,3 M €	+39.6%	918,8 k €	-47.6%	1,8 M €	+17.7%	1,5 M €	+15.3%	1,3 M €	+179%	463,1 k €	+40.8%	328,8 k €	+20.0%	274 k €	+17.3%	233,7 k €	+16.0%	201,5 k €	-0.2%	201,9 k €	+42.4%	141,8 k €	-16.6%	169,9 k €	+49.2%	113,8 k €	-16.3%	136 k €	+56.9%	86,7 k €	+41.5%	61,3 k €
Cash	103,4 k €	-29.5%	146,7 k €	+34.6%	109 k €	-49.3%	215 k €	-2.4%	220,3 k €	+59.5%	138,2 k €	+7.7%	128,3 k €	-7.3%	138,4 k €	-15.3%	163,3 k €	+27.8%	127,8 k €	+38.8%	92 k €	+136%	39 k €	-53.8%	84,4 k €	+37.4%	61,4 k €	-49.1%	120,7 k €	+50.6%	80,1 k €	+110%	38,2 k €
Debts	1,1 M €	+1000%	103,8 k €	-77.1%	452,8 k €	-6.9%	486,5 k €	+5.2%	462,6 k €	+1863%	23,6 k €	+131%	10,2 k €	-72.2%	36,7 k €	-49.9%	73,3 k €	+90.5%	38,5 k €	-64.1%	107,1 k €	-15.9%	127,3 k €	+126%	56,2 k €	-43.3%	99,1 k €	+124%	44,3 k €	+52.9%	29 k €	+15.9%	25 k €
Other
Workforce	4,9 ETP	-2.0%	5,0 ETP		–		–		–		–		–		–		–		–		–		0,4 ETP		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 3 ended

Active mandates

Ter Loonst

Persoon belast met dagelijks bestuur · since 13 avril 2026 · 0536.854.616

Represented by Caroline Steensels

Active

Emmanuel Vanderhaegen

Director · since 02 avril 2026

Active

Jeremy Dielen

Director · since 02 avril 2026

Active

Patrick Van Dooren

Director · since 02 avril 2026

Active

Ended mandates

Isabelle Geeraert

Mandate

Ended

ISABELLE GEERAERT

Director

Ended

ISABELLE GEERAERT

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Apis Activa● Active	1018.570.571
Te Bastis● Active	1042.497.996

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	19/05/2025	17/07/2024	20/06/2023	13/07/2022	15/07/2021
General meeting	20/06/2026	22/04/2025	15/06/2024	17/06/2023	18/06/2022	19/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/06/2026	22/06/2026	Dutch	PDF
Abridged model	31/12/2024	22/04/2025	19/05/2025	Dutch	PDF
Micro model	31/12/2023	15/06/2024	17/07/2024	Dutch	PDF
Micro model	31/12/2022	17/06/2023	20/06/2023	Dutch	PDF
Micro model	31/12/2021	18/06/2022	13/07/2022	Dutch	PDF
Micro model	31/12/2020	19/06/2021	15/07/2021	Dutch	PDF
Micro model	31/12/2019	20/06/2020	29/06/2020	Dutch	PDF
Micro model	31/12/2018	15/06/2019	26/06/2019	Dutch	PDF
Micro model	31/12/2017	16/06/2018	21/06/2018	Dutch	PDF
Micro model	31/12/2016	17/06/2017	22/06/2017	Dutch	PDF
Abridged model	31/12/2015	18/06/2016	30/06/2016	Dutch	PDF
Abridged model	31/12/2014	20/06/2015	23/06/2015	Dutch	PDF
Abridged model	31/12/2013	21/06/2014	26/06/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	12/07/2013	Dutch	PDF
Abridged model	31/12/2011	16/06/2012	28/09/2012	Dutch	PDF
Abridged model	31/12/2010	31/03/2011	24/06/2011	Dutch	PDF
Abridged model	31/12/2009	19/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	30/09/2009	30/09/2009	Dutch	PDF
Abridged model	31/12/2007	21/06/2008	23/09/2008	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 3 ended

Active mandates

Ter Loonst

Persoon belast met dagelijks bestuur · since 13 avril 2026 · 0536.854.616

Represented by Caroline Steensels

Active

Emmanuel Vanderhaegen

Director · since 02 avril 2026

Active

Jeremy Dielen

Director · since 02 avril 2026

Active

Patrick Van Dooren

Director · since 02 avril 2026

Active

Ended mandates

Isabelle Geeraert

Mandate

Ended

ISABELLE GEERAERT

Director

Ended

ISABELLE GEERAERT

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring11/05/2026
MET FUSIE DOOR OVERNEMING GELIJKGESTELDE VERRICHTING (door
PDF
Restructuring18/02/2026
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates07/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/08/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Registered office19/05/2009
MAATSCHAPPELIJKE ZETEL
PDF
Other13/09/2006
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025349,1 k €↓
2024
Annual accounts 2024694,6 k €↑
2023
Annual accounts 2023378,5 k €↑
2022
Annual accounts 2022307,5 k €↑
2021
Annual accounts 2021206,5 k €↑
2018
Annual accounts 2018124,7 k €↑
2017
Annual accounts 201781 k €↑
2016
Annual accounts 201677 k €↑
2015
Annual accounts 201564,4 k €↓
2014
Annual accounts 201468,5 k €↓
2013
Annual accounts 201380,2 k €↑
2012
Annual accounts 201278 k €↓
2011
Annual accounts 201198,9 k €↑
2010
Annual accounts 201060,4 k €↑
2009
Annual accounts 200934 k €↑
2008
Annual accounts 200821,4 k €↓
2007
Annual accounts 200729,9 k €
05/09/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

STUDIO PHARMA

Overview

What does STUDIO PHARMA do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline